Stefano Margaritora

Medicine and Dentistry

1. Adenocarcinoma 10%
2. Adjuvant Therapy 12%
3. Cancer 19%
4. Carcinoid 21%
5. Chemoradiotherapy 24%
6. Chemotherapy 17%
7. Chest Tube 15%
8. Computer Assisted Tomography 13%
9. Disease Free Survival 25%
10. Diseases 30%
11. Epithelioma 18%
12. Hazard Ratio 9%
13. Histology 17%
14. Lobectomy 53%
15. Long Term Survival 15%
16. Long-Term Outcome 11%
17. Lung 45%
18. Lung Adenocarcinoma 15%
19. Lung Cancer 40%
20. Lung Function 13%
21. Lung Metastasis 12%
22. Lymph Node 11%
23. Metastasectomy 14%
24. Metastatic Carcinoma 14%
25. Morbidity 12%
26. Myasthenia gravis 28%
27. Neoadjuvant Therapy 9%
28. Neoplasm 33%
29. Neuroendocrine Tumor 12%
30. Non Small Cell Lung Cancer 100%
31. Non-Small Cell Lung Cancer 24%
32. Overall Survival 36%
33. Pneumonectomy 50%
34. Pneumothorax 19%
35. Positron Emission Tomography-Computed Tomography 9%
36. Prognostic Factor 34%
37. Proportional Hazards Model 9%
38. Quality of Life 12%
39. Radiation Therapy 14%
40. Recurrent Disease 36%
41. Retroperitoneal Lymph Node Dissection 14%
42. Solitary Fibrous Tumor 9%
43. Surgeon 16%
44. Surgery 28%
45. Thoracic Wall 16%
46. Thorax Surgery 19%
47. Thymectomy 20%
48. Thymus Cancer 45%
49. Tumor 30%
50. Video-Assisted Thoracoscopic Surgery 54%